Cargando…
Lysophosphatidic acid enhances neointimal hyperplasia following vascular injury through modulating proliferation, autophagy, inflammation and oxidative stress
Lysophosphatidic acid (LPA), which is one of the intermediate products of membrane phospholipid metabolism, is a bioactive phospholipid that possesses diverse activities. In the present study, the effects of LPA on neointimal formation following vascular injury were investigated. A carotid artery ba...
Autores principales: | Shen, Xuhui, Zou, Jianjun, Li, Fuyong, Zhang, Tianhe, Guo, Tongqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059717/ https://www.ncbi.nlm.nih.gov/pubmed/29749484 http://dx.doi.org/10.3892/mmr.2018.8937 |
Ejemplares similares
-
Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia
por: Ko, Dai Sik, et al.
Publicado: (2022) -
Celastrol ameliorates vascular neointimal hyperplasia through Wnt5a-involved autophagy
por: Shi, Ya-Ning, et al.
Publicado: (2021) -
Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation
por: Wu, Wen, et al.
Publicado: (2019) -
Cholinergic anti-inflammatory pathway inhibits neointimal hyperplasia by suppressing inflammation and oxidative stress
por: Li, Dong-Jie, et al.
Publicado: (2017) -
Anemoside B4 Inhibits Vascular Smooth Muscle Cell Proliferation, Migration, and Neointimal Hyperplasia
por: Shan, Dan, et al.
Publicado: (2022)